Artiva is effectively shutting down and cutting almost all staff after two patient deaths in its autoimmune cell therapy trials.
endpoints.newsArtiva to wind down after two patient deaths in autoimmune cell therapy trialsResearchers had been testing whether Artiva's off-the-shelf NK cell therapy called AB-101 could treat rheumatoid arthritis and other autoimmune diseases.
0 reposts0 likes